logo

For the Inventor, By the Inventor

Rockville, MD, United States of America

Charles E Myers

USPTO Granted Patents = 11

Average Co-Inventor Count = 2.7

ph-index = 5

Forward Citations = 99(Granted Patents)


Location History:

  • Bethesda, MD (US) (1992)
  • Rockville, MD (US) (1982 - 2000)
  • Sandy, UT (US) (1999 - 2000)

Company Filing History:

goldMedal6 out of 1,217 
 
The United States of America As Represented by the Department of Health
 patents
silverMedal2 out of 2,202 
 
The United States of America As Represented by the Secretary of
 patents
bronzeMedal1 out of 3,539 
 
The United States of America, As Represented by the Secretary, Department of Health and Human Services
 patents
where one patent can have more than one assignee

Years Active: 1982-2000

Loading Chart...
11 patents (USPTO):Explore Patents
1. 6040334 - Use of inhibitors of 3-hydroxy-3-methylglutaryl coenzyme a reductase as (2000-03-21),
2. D419101 - Protector for wrist watch lens or the like (2000-01-18),
3. D410865 - Protector for wrist watch lens (1999-06-15),
4. 5792657 - Steroid secreting human adrenocortical carcinoma cell lines (1998-08-11),
5. 5641500 - Use of purinergic receptor agonists as antineoplastic agents (1997-06-24),
6. 5602184 - Monoterpenes, sesquiterpenes and diterpenes as cancer therapy (1997-02-11),
7. 5415873 - Use of purinergic receptor agonists as antineoplastic agents (1995-05-16),
8. 5173509 - Suramin and active analogues thereof in the treatment of hypercalcemia (1992-12-22),
9. 5158940 - Use of suramin to treat rheumatologic diseases (1992-10-27),
10. 4986256 - Use of paramagnetic metalloporphyrins as contrast agents for tumors in (1991-01-22),
11. 4331648 - N-Acetyl-cysteine protects against cardiac damage from (1982-05-25),

Title: The Innovations of Charles E. Myers

Introduction

Charles E. Myers is a notable inventor based in Rockville, MD (US), recognized for his contributions to the field of medical treatments. With a total of 11 patents, he has made significant strides in developing methods for treating various cancers.

Latest Patents

One of his latest patents focuses on the use of inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase. This patent outlines methods for treating cancers, such as prostatic adenocarcinoma, using inhibitors like lovastatin. The patent includes details on dosing ranges, schedules, and potential toxicities associated with the treatment.

Career Highlights

Throughout his career, Charles E. Myers has worked with prominent organizations, including the United States of America as represented by the Department of Health and the United States of America as represented by the Secretary of Health. His work has had a lasting impact on cancer treatment methodologies.

Collaborations

Charles has collaborated with esteemed colleagues, including Jane B. Trepel and Cy A. Stein, contributing to the advancement of medical research and innovation.

Conclusion

Charles E. Myers exemplifies the spirit of innovation in the medical field, with his patents paving the way for new cancer treatment options. His work continues to influence the landscape of medical research and patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…